Nocturia, Nocturnal Incontinence Prevalence, and Response to Anticholinergic and Behavioral Therapy

Overview

Journal Int Urogynecol J Pelvic Floor Dysfunct

Specialties Gynecology & Obstetrics
Urology

Date 2008 Aug 16

PMID 18704249

Citations 3

Authors

M P Fitzgerald

G Lemack

T Wheeler

H J Litman

Affiliations

Soon will be listed here.

Abstract

To determine whether participants in the behavior enhances drug reduction of incontinence (BE-DRI) trial experienced reduction in the frequency of nocturia and/or nocturnal leakage during treatment with antimuscarinic phamacotherapy with or without additional behavioral therapy. We analyzed urinary diary data relating to nocturia and nocturnal incontinence before and after 8 weeks of study treatment in the BE-DRI trial, in which patients were randomly assigned to receive drug therapy with tolterodine tartrate extended-release capsules 4 mg alone or in combination with behavioral training. Chi-square tests assessed whether nocturia and nocturnal incontinence prevalence varied by treatment arm and paired t tests assessed the change in mean frequency of nocturia and nocturnal leakage. Among 305 women, 210 (69%) had an average of at least one nocturia episode at baseline. There were small but statistically significant differences (p < 0.001) in mean nocturia frequency and nocturnal incontinence frequency with both treatments after 8 weeks, but no significant difference between study treatment groups. Among these urge incontinent women, tolterodine with or without supervised behavioral therapy had little impact on either nocturic frequency or nocturnal incontinence.

Citing Articles

A multisite feasibility study of integrated cognitive-behavioral treatment for co-existing nocturia and chronic insomnia.

Fung C, Huang A, Markland A, Schembri M, Martin J, Bliwise D J Am Geriatr Soc. 2024; 73(2):558-565.

PMID: 39389800 PMC: 11825994. DOI: 10.1111/jgs.19214.

Association between the Urinary Bladder Volume and the Incidence of "De Novo" Overactive Bladder in Patients with Stress Urinary Incontinence Subjected to Sling Surgeries or Burch Procedure.

Ciecwiez S, Chelstowski K, Brodowska A, Ptak M, Kotlega D, Starczewski A Biomed Res Int. 2019; 2019:9515242.

PMID: 30891460 PMC: 6390252. DOI: 10.1155/2019/9515242.

Pelvic floor muscle training added to another active treatment versus the same active treatment alone for urinary incontinence in women.

Ayeleke R, Hay-Smith E, Omar M Cochrane Database Syst Rev. 2015; (11):CD010551.

PMID: 26526663 PMC: 7081747. DOI: 10.1002/14651858.CD010551.pub3.

Management of nocturia in the female.

Chang A, Lee E, Lucioni A Curr Urol Rep. 2015; 16(3):10.

PMID: 25677234 DOI: 10.1007/s11934-015-0485-y.

References

Van Kerrebroeck P, Abrams P, Chaikin D, Donovan J, Fonda D, Jackson S . The standardisation of terminology in nocturia: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn. 2002; 21(2):179-83. DOI: 10.1002/nau.10053. View

Asplund R, Aberg H . Nocturia and health in women aged 40-64 years. Maturitas. 2000; 35(2):143-8. DOI: 10.1016/s0378-5122(00)00111-0. View

Johnson 2nd T, Burgio K, Redden D, Wright K, Goode P . Effects of behavioral and drug therapy on nocturia in older incontinent women. J Am Geriatr Soc. 2005; 53(5):846-50. DOI: 10.1111/j.1532-5415.2005.53260.x. View

Weiss J, Blaivas J, Jones M, Wang J, Guan Z . Age related pathogenesis of nocturia in patients with overactive bladder. J Urol. 2007; 178(2):548-51. DOI: 10.1016/j.juro.2007.03.117. View

Asplund R, Aberg H . Health of the elderly with regard to sleep and nocturnal micturition. Scand J Prim Health Care. 1992; 10(2):98-104. DOI: 10.3109/02813439209014044. View

Coyne K, Zhou Z, Bhattacharyya S, Thompson C, Dhawan R, Versi E . The prevalence of nocturia and its effect on health-related quality of life and sleep in a community sample in the USA. BJU Int. 2003; 92(9):948-54. DOI: 10.1111/j.1464-410x.2003.04527.x. View

Brubaker L, Fitzgerald M . Nocturnal polyuria and nocturia relief in patients treated with solifenacin for overactive bladder symptoms. Int Urogynecol J Pelvic Floor Dysfunct. 2006; 18(7):737-41. DOI: 10.1007/s00192-006-0239-y. View

Diokno A, Brock B, Brown M, Herzog A . Prevalence of urinary incontinence and other urological symptoms in the noninstitutionalized elderly. J Urol. 1986; 136(5):1022-5. View

Asplund R . Pharmacotherapy for nocturia in the elderly patient. Drugs Aging. 2007; 24(4):325-43. DOI: 10.2165/00002512-200724040-00005. View

10.

Rackley R, Weiss J, Rovner E, Wang J, Guan Z . Nighttime dosing with tolterodine reduces overactive bladder-related nocturnal micturitions in patients with overactive bladder and nocturia. Urology. 2006; 67(4):731-6. DOI: 10.1016/j.urology.2005.10.061. View

11.

Asplund R . Hip fractures, nocturia, and nocturnal polyuria in the elderly. Arch Gerontol Geriatr. 2006; 43(3):319-26. DOI: 10.1016/j.archger.2005.12.002. View

12.

Fitzgerald M, Litman H, Link C, McKinlay J . The association of nocturia with cardiac disease, diabetes, body mass index, age and diuretic use: results from the BACH survey. J Urol. 2007; 177(4):1385-9. DOI: 10.1016/j.juro.2006.11.057. View

13.

. Design of the Behavior Enhances Drug Reduction of Incontinence (BE-DRI) study. Contemp Clin Trials. 2006; 28(1):48-58. DOI: 10.1016/j.cct.2006.06.002. View

14.

Lowenstein L, Brubaker L, Kenton K, Kramer H, Shott S, Fitzgerald M . Prevalence and impact of nocturia in a urogynecologic population. Int Urogynecol J Pelvic Floor Dysfunct. 2007; 18(9):1049-52. DOI: 10.1007/s00192-006-0289-1. View

15.

Van Balen R, Steyerberg E, Polder J, Ribbers T, Habbema J, Cools H . Hip fracture in elderly patients: outcomes for function, quality of life, and type of residence. Clin Orthop Relat Res. 2001; (390):232-43. View